Table 1 Patient characteristics
Parameter | Total cohort (n = 104) | PCR cohort (n = 71) |
|---|---|---|
Demographics | ||
Age (years) | 43.5 ± 1.77; 42 (18–92) | 41.6 ± 2.0; 40 (18–80) |
Sex (male/female) | 77/27 | 52/19 |
Glasgow Coma Scale | 11.9 ± 0.41; 14 (3–15) | 11.9 ± 0.5; 14 (3–5) |
Injury Severity Score | 32.8 ± 1.3; 31 (17–75) | 31 ± 1.5; 29 (13–75) |
SOFA score initial | 4.8 ± 0.3; 5 (0–12) | 4.19 ± 0.4; 4 (0–12) |
SOFA score maximum | 7.7 ± 0.4; 8 (0–18) | 6.9 ± 0.5; 7 (0–18) |
Outcomes | ||
RISC (% survival) | 83.3 ± 2.5 | 85 ± 2.8; 96.3 (9.8–98.9) |
Survival | 88 % (13 nonsurvivors) | 90 % (7 nonsurvivors) |
Hospital length of stay (days) | 26.6 ± 1.8; 21.5 (2–119) | 25 ± 2.1; 20 (3–119) |
Intensive care unit length of stay (days) | 13.9 ± 1.4; 10 (2–86) | 11.2 ± 1.2; 8 (2–47) |
Allogenic blood transfusion | ||
TASH score (points) | 8.5 ± 0.6; 8 (0–23) | 7.8 ± 0.7; 7 (0–23) |
TASH (%) | 13.9 ± 2.0 | 12.4 ± 2.2; 5 (5–82) |
Initial (day 0) pRBC transfusion (units) | 4.0 ± 0.8; 1 (0–54) | 3.1 ± 0.7; 0 (0–28) |
Total pRBC transfusion | 9.6 ± 1.3; 5 (0–70) | 7.8 ± 1.2; 4 (0–58) |
Infectious complications | ||
Nosocomial infections | 56/104 (53.9 %) | 34/71 (48 %) |
Sepsis | 15/104 (14.0 %) | 10/71 (14.1 %) |